Latest Novo Nordisk News & Updates
See the latest news and media coverage for Novo Nordisk. We track all announcements, press releases, and industry mentions in real time, all in one place.
Global healthcare company focused on diabetes and obesity
novonordisk.com- Headquarters
- Bagsværd, Denmark
- Founded year
- 1923
- Company type
- Public company
- Number of employees
- 60,000+
Latest news about Novo Nordisk
Company announcements
-
Novo Nordisk ranks among TIME's 100 Most Influential Companies 2026
The recognition honors their disruption in obesity treatment and GLP-1 science for patients worldwide.
-
Novo Nordisk publishes phase 3 data on denecimig
Data shows significantly reduced annualized bleeding rate in haemophilia A patients, regardless of inhibitor status, versus prior prophylaxis or on-demand treatment.
-
Novo Nordisk presents new Wegovy data at Obesity Congress
Data covers higher-dose Wegovy, oral semaglutide, and CagriSema, focusing on weight loss, menopausal symptoms, and cardiovascular risk.
-
Novo Nordisk announces positive PIONEER TEENS trial results
Oral semaglutide shows superior HbA1c reduction versus placebo in children and adolescents aged 10-17 with type 2 diabetes. Novo Nordisk plans regulatory filings in US and EU.
Media coverage
-
French fines over anti-obesity adverts for Novo Nordisk, Eli Lilly
As French laws prohibit any advertising to the general public of the treatments, Novo Nordisk France was fined €1.78 million, and Lilly France was fined...
-
Pill war will be decisive for Novo success - soon the time of reckoning comes
Wednesday, Novo Nordisk releases the financial report for the year's first quarter. Now come the first indications of whether Mike Doustdar's strategy bears fruit. That assesses analyst, Søren...
-
Novo Nordisk Extends Pipeline With Semaglutide Alcohol Study And LX9851 Trial
Novo Nordisk (NYSE:NVO) is exploring semaglutide as a potential treatment for alcohol use disorder,...
-
Novo Nordisk to launch Ozempic for type 2 diabetes in US
Novo Nordisk is set to launch Ozempic, its oral glucagon-like peptide-1 (GLP-1) receptor agonist...
Track Novo Nordisk and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.
Trending companies
Discover what's making headlines across other trending companies.
Sironax
Aperture Therapeutics
Attentive
Klaviyo
Twilio
Insider One
Zeta Global
Iterable
Braze
Optimove
Bluecore
BlueConic
Amperity
Wero
BLIK
EPI
Swish
Affirm
Brite Payments
TCS
Overview Energy
Adfin
Ineffable Intelligence
Mechanize
Hexatronic
Alimak Group
Lindab Group
NYAB
Noon Energy
Nordan AI
Mips
Vexlum
Asker Healthcare Group
FAKRO